VVUS

VIVUS, Inc. News Headlines

$2.31
*  
0.01
0.43%
Get VVUS Alerts
*Delayed - data as of Jul. 2, 2015  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



Vivus Beats The Street - Still Has A Loss
8/8/2014 10:04:00 AM - Seeking Alpha




Orexigen Hits Expectations But That Is Not The Big News
8/7/2014 1:25:00 PM - Seeking Alpha








2nd Half Of 2014 Biotechnology Catalysts-Part 3
8/4/2014 2:36:00 PM - Seeking Alpha




Possible Delay In Orexigen Approval Process In Europe
7/31/2014 9:54:00 AM - Seeking Alpha








Arena's Belviq Sales Flat Again
6/27/2014 12:37:00 PM - Seeking Alpha


The Anti-Obesity Space Is Not As Simple As Some Think
6/20/2014 11:34:00 AM - Seeking Alpha


What Will It Take For Arena Stock To Rise?
6/16/2014 4:19:00 PM - Seeking Alpha


Vivus Suit Preserves Exclusivity Of Qsymia - For Now
6/13/2014 2:56:00 PM - Seeking Alpha




Orexigen Investors Hope For FDA Approval
6/10/2014 1:22:00 PM - Seeking Alpha


Orexigen Could Be A Double-Edged Sword For Arena
6/9/2014 5:22:00 PM - Seeking Alpha


Arena Pharmaceuticals: Strong Sell On Multiple Red Flags
6/6/2014 1:15:00 PM - Seeking Alpha




Belviq Sales Climb - Are Ads Effective?
5/30/2014 4:46:00 PM - Seeking Alpha


A Vivus Buyout? Fat Chance And A Good Time To Short
5/30/2014 12:30:00 PM - Seeking Alpha